Biostax Corp (BTAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17 | 35 | 151 | 185 | 272 |
| Marketable Securities | N/A | N/A | N/A | 6 | N/A |
| TOTAL | $17 | $35 | $151 | $191 | $272 |
| Non-Current Assets | |||||
| Intangibles | 736 | 749 | 763 | 0 | 0 |
| Other Non-Current Assets | 6 | 13 | 51 | 0 | 0 |
| TOTAL | $741 | $762 | $813 | $N/A | $N/A |
| Total Assets | $759 | $797 | $964 | $191 | $272 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,538 | 1,722 | 1,850 | 1,385 | 1,431 |
| Accrued Expenses | 576 | 566 | 537 | 647 | 3,152 |
| Other current liabilities | 635 | 442 | 395 | 90 | 1,180 |
| TOTAL | $3,861 | $3,576 | $3,477 | $2,793 | $6,841 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,861 | $3,576 | $3,477 | $2,793 | $6,841 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 83,621 | 83,296 | 83,296 | 82,762 | 71,079 |
| Common Shares | 8 | 8 | 8 | 8 | 2 |
| Retained earnings | -383,889 | -383,385 | -382,969 | -382,690 | -380,196 |
| Other shareholders' equity | 10 | 10 | 10 | 10 | 10 |
| TOTAL | $-3,102 | $-2,780 | $-2,514 | $-2,602 | $-6,570 |
| Total Liabilities And Equity | $759 | $797 | $964 | $191 | $272 |